A recent General Practice digest,
as sent to subscribers

Study Type: Retrospective population-based cohort study

Key Question: What is the plausible prevalence of chronic traumatic encephalopathy (CTE) among deceased former NFL players, and how does CTE severity relate to dementia risk?

Key Findings:

• Among all 1712 deceased NFL players (2008-21), possible CTE prevalence ranged widely (18.5%–98.7%); during 2016-21 (peak donation period), the range narrowed to 24.5%–97.7%, suggesting a true minimum of roughly one-quarter.
• Among 338 brain donors, 93.2% had CTE and 30.8% had stage IV disease; stage IV CTE was associated with a 44% higher risk of clinician-diagnosed dementia (RR 1.44, 95% CI 1.16–1.78, p<0.001).
• Neurodegenerative disease was recorded as cause of death in only 18.6% of donors and in just 40.6% of those with confirmed dementia, indicating substantial under-recognition on death certificates.

Clinical Relevance: Highlights that repetitive head impact-related neurodegeneration is likely underdiagnosed and under-certified, reinforcing the need for GPs to consider CTE/dementia risk when assessing cognitive symptoms in patients with significant contact-sport histories (relevant to UK rugby/football concussion pathways).

Limitations: Selection bias is substantial, as brain donation was voluntary and likely over-represents symptomatic players, limiting generalisability of prevalence estimates.

Study Type: Narrative review

Key Question: What is the current state of knowledge on schizophrenia's pathophysiology and management, and how might precision medicine improve future treatment?

Key Findings:

• Schizophrenia arises from combined genetic and environmental factors with neurodevelopmental underpinnings; onset typically occurs in late adolescence/young adulthood.
• Established antipsychotic drugs reduce positive symptoms and relapse risk, while psychosocial/cognitive interventions support functional recovery and early psychosis management; neuromodulation and digital health interventions remain investigational.
• Current diagnostic criteria capture a biologically heterogeneous population, limiting drug development; biomarker-driven patient stratification is proposed as the next step toward precision medicine.

Clinical Relevance: UK GPs manage patients with schizophrenia long-term in primary care (physical health monitoring, relapse recognition, medication adherence) and should anticipate future shifts toward biomarker-based, stratified treatment approaches within shared care pathways.

Limitations: As a narrative review, it does not systematically appraise evidence quality or provide pooled effect estimates for specific interventions.

Study Type: Scoping review (37 studies included, PRISMA-ScR methodology)

Key Question: How well do general practitioners adhere to cardiovascular disease clinical practice guidelines, and what factors influence this adherence?

Key Findings:

• Reported guideline adherence varied widely (4%–100%) depending on disease area, guideline, and measurement method.
• Key barriers included time constraints, systemic/organisational factors, and guideline limitations (e.g., poor applicability to complex or multimorbid patients).
• Complex cases often prompted deliberate deviation from guidelines due to concerns about side effects and treatment burden.

Clinical Relevance: Highlights that despite good awareness of CVD guidelines, UK GPs managing multimorbid patients face legitimate, recurring barriers to strict adherence—supporting calls for more pragmatic, GP-informed guideline design (relevant to NICE guideline development and QOF-type adherence metrics).

Limitations: Predominantly cross-sectional, heterogeneous studies with inconsistent adherence definitions limit direct comparability and causal inference.

Study Type: Cross-sectional diagnostic validation study

Key Question: Can an AI-based, symbol-driven drawing platform match or improve upon manual Clock Drawing Test scoring for distinguishing Alzheimer's disease from healthy ageing in primary care?

Key Findings:

• AI model achieved AUC 0.868, with a cut-off <27 points yielding 83.6% sensitivity and 75.0% specificity; substantial agreement with clinical diagnosis (κ = 0.586, P<0.001).
• AI score was an independent predictor of AD status after adjusting for age/gender (OR 0.940, 95% CI 0.904–0.979, P<0.001).
• AI flagged 25% of "cognitively intact" controls (per manual CDT) as at-risk, suggesting greater sensitivity to subtle visuoconstructional deficits.

Clinical Relevance: This tool could offer GPs an objective, language- and literacy-independent, low-cost tablet-based triage aid to identify patients needing earlier memory clinic referral, potentially improving early AD detection within NHS primary care pathways.

Limitations: Cross-sectional design with modest sample size (n=111) limits generalisability and cannot establish longitudinal predictive validity or real-world implementation outcomes.

Study Type: National cross-sectional survey/quality improvement evaluation (not an RCT or systematic review).

Key Question: How consistent is point-of-care ultrasound (POCUS) education across Canadian internal medicine residency programmes when assessed using standardised education indicators?

Key Findings:

• All 17 Canadian IM programmes participated; median POCUS faculty was 1 (range 0–5), with median 18 hours annual teaching time (range 0–204 hours).
• Only 1 programme had assessment processes for all learners; 59% lacked any image archiving or feedback system; only 35% conducted formal programme evaluation.
• Enhanced ("superuser") streams existed in 35% of programmes, offering substantially more teaching time (median 161 extra hours), but feedback provision remained inconsistent even within these.

Clinical Relevance: Highlights marked variability in POCUS training quality and oversight, relevant to UK GP/IM educators considering POCUS integration into curricula, particularly regarding governance, competency assessment, and quality assurance standards akin to RCP/RCGP ultrasound accreditation frameworks.

Limitations: Findings are specific to the Canadian training context and rely on self-reported programme-level data, limiting direct generalisability and objectivity.

Study Type: Longitudinal cohort evaluation (single-centre curriculum intervention study)

Key Question: Does individualized, analytics-informed coaching improve residents' EHR inbasket efficiency and reduce burnout?

Key Findings:

• Turnaround time for patient calls improved significantly (–2.2 days, p<0.001); mean time in patient calls decreased (0.99→0.74 min/day, p=0.03).
• Resident-perceived burnout, confidence, and efficiency showed no significant change (p=0.09, 0.18, 0.56 respectively).
• Faculty (6/7) rated EHR analytics as at least moderately useful for coaching and improving feedback quality.

Clinical Relevance: As NHS trainees face similar EHR-related administrative burden and burnout pressures, this model demonstrates a feasible, structured coaching approach using objective data to improve measurable efficiency, relevant to UK postgraduate training and workplace-based feedback frameworks.

Limitations: Single-centre, small sample with self-reported secondary outcomes limits generalisability and ability to detect burnout/confidence changes.

Study Type: Cross-sectional analysis of nationally representative survey data (US, NSDUH 2022–2023)

Key Question: Among US adults with alcohol or opioid use disorder, who receives pharmacotherapy, and how is receipt associated with healthcare utilisation?

Key Findings:

• Only 4.8% of adults with AUD/OUD reported receiving addiction pharmacotherapy in the past 12 months.
• Pharmacotherapy receipt was associated with higher, not lower, healthcare utilisation: ED visits (IRR 1.57, 95% CI 1.16–2.14), nights hospitalised (IRR 2.79, 95% CI 1.10–4.87), and outpatient visits (IRR 1.28, 95% CI 1.02–1.60).
• Findings likely reflect reverse causation—pharmacotherapy often initiated after acute decompensation rather than pre-emptively in primary/outpatient care.

Clinical Relevance: Despite differing systems, this highlights a UK-relevant gap—low uptake of evidence-based pharmacotherapy (e.g., naltrexone, acamprosate, buprenorphine) in primary care, reinforcing the case for proactive screening and treatment initiation in general practice before crisis-driven acute care presentations.

Limitations: Cross-sectional, self-reported data preclude causal inference and cannot rule out confounding by indication or reverse causality.

Study Type: Program evaluation (pilot faculty development intervention, pre/post survey design)

Key Findings:

• 36 VA sites (14 rural, 22 nonrural), 417 attendees participated in a 5-hour virtual faculty development series pairing rural/urban sites for shared learning.
• Post-series surveys showed significantly higher affinity for teaching, improved understanding of educator roles, and increased teaching confidence.
• Participants reported intent to increase behaviours associated with effective clinician educators.

Clinical Relevance: While US Veterans Health Administration-specific, this model of low-cost, scalable virtual faculty development pairing rural and urban sites offers a transferable framework for UK GP trainers and educational supervisors, particularly relevant to addressing rural-urban disparities in postgraduate teaching capacity within the NHS.

Limitations: Evaluation relies on self-reported attitudes and intentions immediately post-intervention, without objective measures of teaching behaviour change or patient/trainee outcomes.